Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024Nicolas de Prost, D Fofana, Fabrice Uhel et al.|Annals of Intensive Care|2024Cited by 13
ICU patients with influenza during the 2025–26 season: a French prospective nationwide cohort studyNicolas de Prost, Slim Fourati, Pierre Bay et al.|medRxiv|2026Cited by 0
Complement augments antibody neutralization of SARS-CoV-2 variantsMartin Groznica, Stephane Marot, Pierre Rosenbaum et al.|Science Translational Medicine|2026Cited by 0